Work

Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real‐World Multicenter Retrospective Study

Year: 2026

Type: article

Study design: Observational Study

Source: International Journal of Urology

DOI: 10.1111/iju.70356

Authors: Ryuma Tanaka, Masanao Shinohara, Yohei Kawashima, Yuya Sekine, Shintaro Narita, Shin Kobayashi, Noriyuki Abe, Hirotake Kodama, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Kazuyuki Numakura, Satoshi Sato, Tomonori Habuchi, Chikara Ohyama, Shingo Hatakeyama

Institutions: Hirosaki University, Ageo Central General Hospital, Akita University, Asahikawa Medical University

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Pfizer, AstraZeneca, Bayer, Takeda Pharmaceutical Company, Sysmex Corporation, Kyorin Pharmaceutical, Astellas Pharma, Ono Pharmaceutical, Japan Society for the Promotion of Science, Janssen Pharmaceuticals

OpenAlex ID: W7125106947

FWCI: 8.225

Cites: 27

Cited by: 3

Related to: 10